I agree.. Having listened to the call myself this morning live; with CW firing on all cylinders at TEVA. It was an impressive display of confidence.
The problem is not enough people understand MNTA and their science behind the approval they received for enoxaparin. It is not a coincidence that the FDA sought out MNTA and their scientists to help with the Baxter heparin contamination issues in 2008.
Lets think about this for a second. The FDA reaches out to a company that has NO approved products on the market and only an ANDA for m-enox. What was the reason for this? They had a hunch? Or did they recognize their ability in that area?